Clinical trial
Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for…
NCT00141765 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00141765 |
|---|---|
| Title | Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers |
| Official title | Myeloablative Chemotherapy With Stem Cell Rescue for Rare Poor-Prognosis Cancers |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Wilms Tumor, Fibrosarcoma, Carcinoma, Round Cell, Nasopharyngeal Cancer, Brain Tumor, Recurrent |
| Intervention type | Procedure |
| Interventions | Myeloablative Chemotherapy, Stem Cell Rescue |
| Enrollment | 25 |
| Start date | Jan 1, 1997 |
| Primary completion | Dec 1, 2008 |
| Completion | Feb 1, 2010 |
| First posted | Sep 1, 2005 |
| Last update posted | Jun 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: